Growth Potential Assertio has demonstrated recent financial improvement by surpassing earnings estimates and maintaining positive quarterly results, indicating a strengthening market position and potential for increased market share in oncology, neurology, and pain management segments.
Product Focus The company's specialization in differentiated pharmaceutical products aimed at addressing specific patient needs presents opportunities to connect with healthcare providers and institutions seeking innovative treatments within these therapeutic areas.
Leadership Transition With a recent leadership change appointing a seasoned industry veteran as CEO, Assertio may be open to new strategic partnerships and collaborations to accelerate product development and market expansion efforts.
Funding & Growth Having secured substantial funding of $60 million and operating within revenue ranges of $25M to $50M, Assertio is positioned to invest in new product pipelines, licensing deals, or distribution partnerships to accelerate growth.
Competitive Landscape Despite recent setbacks in securities litigation and a designation as a strong sell stock by analysts, Assertio’s focus on niche therapeutic areas and recent financial improvements suggest opportunities for targeted sales efforts to healthcare providers and specialty pharmacies looking for differentiated treatments.
$250M$500M
$1B$10B
$1B$10B
$10B
$1B$10B
$10B
$1B$10B
$250M$500MAssertio uses 8 technology products and services including Google Cloud, Slick, Priority Hints, and more. Explore Assertio's tech stack below.
| Assertio Email Formats | Percentage |
| FLast@assertiotx.com | 79% |
| First.Last@assertiotx.com | 18% |
| LastFirst@assertiotx.com | 2% |
| First-Last@assertiotx.com | 1% |
Pharmaceutical ManufacturingUnited States51-200 Employees
Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. Ticker symbol: ASRT
Company Overview
Funding & FinancialsAssertio has raised a total of $60M of funding over 6 rounds. Their latest funding round was raised on Aug 22, 2022 in the amount of $60M.
Assertio's revenue is estimated to be in the range of $25M$50M
Funding & FinancialsAssertio has raised a total of $60M of funding over 6 rounds. Their latest funding round was raised on Aug 22, 2022 in the amount of $60M.
Assertio's revenue is estimated to be in the range of $25M$50M
1-888-653-2347 
support@leadiq.com